Related Experiment Video
Updated: Jun 7, 2025
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Machine learning-driven discovery of novel therapeutic targets in diabetic foot ulcers
1Pediatric Oncology of the First Hospital of Jilin University, Changchun, 130021, China.
Background:
To utilize machine learning for identifying treatment response genes in diabetic foot ulcers (DFU).
Methods:
Transcriptome data from patients with DFU were collected and subjected to comprehensive analysis. Initially, differential expression analysis was conducted to identify genes with significant changes in expression levels between DFU patients and healthy controls. Following this, enrichment analyses were performed to uncover biological pathways and processes associated with these differentially expressed genes. Machine learning algorithms, including feature selection and classification techniques, were then applied to the data to pinpoint key genes that play crucial roles in the pathogenesis of DFU. An independent transcriptome dataset was used to validate the key genes identified in our study. Further analysis of single-cell datasets was conducted to investigate changes in key genes at the single-cell level.
Results:
Through this integrated approach, SCUBE1 and RNF103-CHMP3 were identified as key genes significantly associated with DFU. SCUBE1 was found to be involved in immune regulation, playing a role in the body's response to inflammation and infection, which are common in DFU. RNF103-CHMP3 was linked to extracellular interactions, suggesting its involvement in cellular communication and tissue repair mechanisms essential for wound healing. The reliability of our analysis results was confirmed in the independent transcriptome dataset. Additionally, the expression of SCUBE1 and RNF103-CHMP3 was examined in single-cell transcriptome data, showing that these genes were significantly downregulated in the cured DFU patient group, particularly in NK cells and macrophages.
Conclusion:
The identification of SCUBE1 and RNF103-CHMP3 as potential biomarkers for DFU marks a significant step forward in understanding the molecular basis of the disease. These genes offer new directions for both diagnosis and treatment, with the potential for developing targeted therapies that could enhance patient outcomes. This study underscores the value of integrating computational methods with biological data to uncover novel insights into complex diseases like DFU. Future research should focus on validating these findings in larger cohorts and exploring the therapeutic potential of targeting SCUBE1 and RNF103-CHMP3 in clinical settings.
Insights
Machine learning identified SCUBE1 and RNF103-CHMP3 as key genes in diabetic foot ulcers (DFU). These genes are downregulated in cured patients, offering potential for new DFU diagnostics and therapies.
Area of Science:
- Genomics
- Bioinformatics
- Immunology
Background:
- Diabetic foot ulcers (DFU) represent a significant clinical challenge.
- Identifying molecular markers for DFU treatment response is crucial for improving patient outcomes.
Purpose of the Study:
- To leverage machine learning (ML) for identifying key genes associated with treatment response in diabetic foot ulcers (DFU).
- To uncover novel molecular targets for DFU diagnosis and therapy.
Main Methods:
- Transcriptome data analysis including differential expression and enrichment analyses.
- Application of ML algorithms for feature selection and classification to identify key DFU-associated genes.
- Validation using an independent transcriptome dataset and single-cell RNA sequencing.
Main Results:
- SCUBE1 and RNF103-CHMP3 were identified as key genes significantly associated with DFU.
- SCUBE1 is implicated in immune regulation, while RNF103-CHMP3 is linked to extracellular interactions and tissue repair.
- These genes were found to be downregulated in cured DFU patients, particularly in NK cells and macrophages.
Conclusions:
- SCUBE1 and RNF103-CHMP3 are potential biomarkers for DFU, offering new avenues for diagnosis and targeted therapies.
- This study highlights the power of integrating computational methods with biological data for disease insight.
- Further validation in clinical settings and exploration of therapeutic targeting are warranted.
